Celgene: GC-LTFU-001 (Multiple Myeloma) - Clinical Trial

What is the Purpose of this Study?

We are doing this study to monitor the health and quality of life of people who participated in clinical trials for GM T cell therapies.

What is the Condition Being Studied?

Multiple Myeloma

Who Can Participate in the Study?

Current or former cancer patients who received a GM T cell infusion as participants in a clinical trial sponsored by Celgene or one of Celgene's research partners.

For more information about who can join this study, please contact the study team at 919-684-9220.

Age Group
Adults

What is Involved?

If you choose to join this study, you will visit our clinic for occasional check-up visits for up to 15 years.

Study Details

Full Title
GC-LTFU-001: LONG-TERM FOLLOW-UP PROTOCOL FOR SUBJECTS TREATED WITH GENE-MODIFIED T CELLS
Principal Investigator
Cellular Therapy Specialist
Protocol Number
IRB: PRO00102299
NCT: NCT03435796
Phase
Phase N/A
ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698